Syros Pharmaceuticals (SYRS)

$0.11 -0.01 (-10.41%)
Market Cap 3.15M
Revenue (ttm) 9.94M
Net Income (ttm) -164.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,655.63%
Debt to Equity Ratio -3.69
Volume 5,682,200
Avg Vol 27,633,414
Day's Range N/A - N/A
Shares Out 26.83M
Stochastic %K 26%
Beta 1.31
Analysts Hold
Price Target $1.00

Latest News on SYRS

No data available.